Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?-Reference-Cited by-同舟云学术

Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Published:2021-11-09 Issue:1 Volume:65 Page:79-87
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Kurland Siri¹^ORCID,Löwdin Elisabeth¹,Furebring Mia¹,Shams Ayda¹,Chryssanthou Erja²^ORCID,Lagerbäck Pernilla¹,Tängden Thomas¹,Breuer Olof³,Sjölin Jan¹

Affiliation:

1. Department of Medical Sciences Uppsala University Uppsala Sweden

2. Department of Clinical Microbiology Karolinska University Hospital Stockholm Sweden

3. Department of Laboratory Medicine Clinical Pharmacology Karolinska Institutet Karolinska University Hospital Stockholm Sweden

Funder

Vetenskapsrådet

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13386

Reference28 articles.

1. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

2. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

3. Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma

4. In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

5. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin;Pharmaceutics;2024-06-17